Recombinant Tissue Plasminogen Activator in Acute Thrombotic and Embolic Stroke
Ann Neurol 32:78-86, delZoppo,G.J.,et al, 1992
Early Computed Tomographic Findings for Thrombolytic Therapy in Patients with Acute Brain Embolism
Stroke 23:20-23, Okada,Y.,et al, 1992
Tissue Plasminogen Activator Plus Glutamate Antagonist Improves Outcome after Embolic Stroke
Arch Neurol 48:1235-1238, Zivin,J.A.&Mazzarella,V., 1991
Antithrombotic Therapy in Cerebrovascular Disease
Ann Int Med 115:885-895, Rothrock,J.F.&Hart,R.G., 1991
CT patterns of Intracranial Hemorrhage Complicating Thrombolytic Therapy for Acute Myocardial Infarction
Radiology 181:555-559, Uglietta,J.P.,et al, 1991
Intracerebral Hemorrhage Related to Cerebral Amyloid Angiopathy and t-PA Treatment
Ann Neurol 29:210-213, Pendlebury,W.W.,et al, 1991
Intracerebral Hemorrhage
Stroke 22:684-691, Feldmann,E., 1991
Cerebrovascular Events After Myocardial Infarction:Analysis of the GISSI Trial
BMJ 302:1428-1431, Maggioni,A.P.,et al, 1991
Reptured Arteriovenous Malformation Complicating Thrombolytic Therapy with Tissue Plasminogen Activator
Arch Neurol 47:105-106, Proner,J.,et al, 1990
Intracranial Hemorrhage After Use of Tissue Plasminogen Activator for Coronary Thrombilysis
Ann Int Med 112:17-21, Kase,C.S.,et al, 1990
Guillain-Barre Syndrome After Streptokinase Therapy
Acta Neurologica Scand 82:153, Roquer,J.,et al, 1990
Ancrod Causes Rapid Thrombolysis in Patients with Acute Stroke
Am J Med Sci 299:319-325, Polla,K.V.E.,et al, 1990
Multiple Microembolic after Disintegration of Clot During Thrombolysis for Acute Myocardial Infarction
BMJ 299:1310-1312, Stafford,P.J.,et al, 1989
Local Intra-Arterial Fibrinolytic Therapy in Acute Carotid Territory Stroke, A Pilot Study
Stroke 19:307-313, delZoppo,G.J.,et al, 1988
Thrombolytic Therapy:Current Status (Second of Two Parts)
NEJM 318:1585-1595, Marder,V.J.&Sherry,S., 1988
Intracarotid Urokinase with Thromboembolic Occlusion of the Middle Cerebral Artery
Stroke 19:802-812, Mori,E.,et al, 1988
Thrombolytic Therapy in Cerebrovascular Disease
Stroke 19:1174-1179, DelZoppo,G.J., 1988
Intra-arterial Thrombolytic Therapy Improves Outcome in Patients with Acute Vertebrobasilar Occlusive Disease
Stroke 19:1216-1222, Hacke,W.,et al, 1988
Fatal Ischaemic Brain Oedema after Early Thrombolysis with Tissue Plasminogen Activator in Acute Stroke
BMJ 297:1571-1574, Koudstaal,P.J.,et al, 1988
Intracerebral Hemorrhage Complicating Intravenous Tissue Plasminogen Activator Treatment
Arch Neurol 45:1070-1073, Carlson,S.E.,et al, 1988
Use of Ancrod in Acute or Progressing Ischemic Cerebral Infarction
Ann Emerg Med 17:1208-1209, Olinger,C.P.,et al, 1988
Current Medical & Surgical Therapy for Cerebrovascular Disease
NEJM 317:1505-1516, Grotta,J.C., 1987
Thrombolysis & Stroke, Past & Future
Arch Neurol 44:748-768, Sloan,M.A., 1987
Thrombolytic Therapy in Stroke:Possibilities & Hazards
Stroke 17:595-607, DelZoppo,G.J.,et al, 1986
Streptokinase & the Guillain-Barre Syndrome
Ann Int Med 103:302, Arrowsmith,J.B.,et al, 1985
Cerebrovascular Complications of Streptokinase Infusion
JAMA 253:1777-1779, Aldrich,M.S.,et al, 1985
Controlled Trial of Ancrod in Ischemic Stroke
Arch Neurol 40:803-808, Hossman,V.,et al, 1983
Heparin-Urokinase Treatment in Aseptic Dural Sinus Thrombosis
Arch Neurol 38:431-435, DiRocco,C.,et al, 1981
Dural Sinus & Cerebral Venous Thrombus
Arch Neurol 22:440, Buchanan,D.S., 1970
Treatment of Strokes
NEJM 281:594, 1969,, Browne,T.,et al, 1969
Treatment of Acute Stroke with Dextran 40
JAMA 210:293, Gilroy,J.,et al, 1969
MR Mismatch Is Useful for Patient Selection for Thrombolysis: No
Stroke 40:2908-2909,2910, Sch�bitz,W.R.,
A 52-Year Old Man with Acute-Onset Blindness
Neurol 106:e214827, Brown,A.M.,et al, 2026
Minimally Invasive Surgery Versus Open Craniotomy with Clot Evacuation after Intracerebral Hemorrhage
Ann Neurol 99:871-880, Murthy, S.B.,et al, 2026
Disseminated Brain Infarcts Associated with Uterine Myoma
Stroke 57:e61-e62, Elbischger,J.,et al, 2026
Anticoagulant Usage and Risk of Thromboembolic Events After Ischemic Stroke in Adults with Cancer
Neurol 105:e214325, Balali,P.,et al, 2025
Minimally Invasive Surgery vs Medical Management Alone for Intracerebral Hemorrhage, The MIND Randomized Clinical Trial
JAMA Neurol 82:1113-1121, Arthur,A.S.,et al, 2025
Functional Outcome in Patients with Carotid Artery Dissection Undergoing Thrombectomy or Standard Medical Treatment
Neurol 104:e213465, Sykora,M.,et al, 2025
Surgical Management of ICH:Past, Present, and Future Prospects
Stroke 56:e355-358, Tarek,M.A.,et al, 2025
"Innumerable" lesion burden on brain MRI - a diagnostic approach
Diagnosis doi.org/10.1515/dx- 2025-2029, Finelli,P.F., 2025
The Multifactorial Nature of Ischemic Stroke in Malignancy
Stroke 56:e303-e306, Doyle,C.L.,et al, 2025
Association of Assisted Reproductive Technology and Stroke During Hospitalization for Delivery in the United States
Stroke 55:999-1005, Dicpinigaitis,A.J.,et al, 2024
Diagnosis of Incident Cancer After Cryptogenic Stroke
Neurol 103:e210027, Navi,B.B.,et al, 2024
Tranexamic Acid Within 4.5 Hours of Intracerebral Hemorrhage With the CTA Spot Sign, Systematic Review and Individual Patient Meta-Analysis
Neurol 103:e210104, Yassi,N.,et al, 2024
Time to Anticoagulation Reversal and Outcomes After Intracerebral Hemorrhage
JAMA Neurol 8:363-372, Sheth,K.M.,et al, 2024
Trial of Early Minimally Invasive Removal of Intracerebral Hemorrhage
NEJM 390:1277-1289,1328, Pradilla,G.,et al, 2024
Treatment Modalities and Outcomes in Brainstem Cavernous Malformations: A Large Multicenter Observational Cohort Study
Stroke 55:1151-1160, Lu,J.,et al, 2024
Code ICH: A Call to Action
Stroke 55:494-505, Li,Q.,et al, 2024
Evolving Role of Imaging in Acute Ischemic Stroke Care
Stroke 55:765-768, Ospel,J.M., & Boulouis,G., 2024
Diagnosis and Management of Cerebral Venous Thrombosis:A Scientific Statement From the American Heart Association
Stroke 55:e77-e90, Saposnik,G.,et al, 2024